Skip to content
Back to Blog
Bio
2026-03-177 min read63

Digital Bio Twin: Drug Process Optimization and New Drug Development Innovation

How digital twin technology is being applied to biopharmaceutical process optimization and drug development, with SME adoption strategies.

KITIM 컨설팅팀

What is a Digital Bio Twin?

A digital bio twin is a virtual replica of biopharmaceutical manufacturing processes or biological systems. By implementing physical, chemical, and biological variables in digital models, simulations that are difficult to perform in laboratories or manufacturing sites can be conducted computationally.

Global pharmaceutical companies are already using digital twins to reduce drug development timelines by 30-40% and improve manufacturing process yields by 10-20%.

Bio Digital Twin Use Cases

1. Cell Culture Process Optimization

Building a digital twin of CHO cell culture processes enables virtual exploration of optimal combinations among dozens of parameters including media composition, temperature, pH, and dissolved oxygen. This maximizes yield while significantly reducing actual culture experiments.

2. Purification Process Scale-up

Simulates commercial-scale purification processes based on laboratory-scale chromatography results. Pre-predicts variables during scale-up to reduce failure risk.

3. Continuous Manufacturing

In biopharmaceutical continuous manufacturing, digital twins enable real-time optimization of process parameters. The 'Digital Twin + AI' combination that automatically adjusts process conditions based on raw material quality variations is gaining attention.

4. Regulatory Submission Support

FDA and EMA are recognizing digital twin-based process understanding in regulatory submissions. Virtual experiment data can be used in approval documents, linked to the ICH Q8 Design Space concept.

SME Bio Company Adoption Strategy

Build Data Foundation First

Digital twin accuracy depends on input data quality. Establish a data management system for systematic collection of process parameters, raw material characteristics, and environmental conditions.

Start with Simple Models

No need to build complex multi-scale models from the start. Begin with a simple model of a single unit process and gradually expand.

Use Cloud-Based Platforms

Building in-house simulation infrastructure is costly. Using cloud-based digital twin platforms minimizes initial investment.

Leverage Industry-Academia Collaboration

Universities possess digital twin modeling capabilities. Government R&D projects with joint industry-academia research provide access to expertise while reducing costs.

Contact KITIM

KITIM supports bio SME digital transformation strategy, process optimization consulting, and government R&D project planning. Contact us through [KITIM Contact](/contact).

Digital TwinBioprocessDrug DevelopmentProcess OptimizationBio DX

Related Posts

Bio

Biologics Approval Fees Rise From KRW 8.03M to 20.71M, Data-Submission Drugs About 6x — MFDS Fee Regulation Amendment Pre-Announced Nov 6, 2026 (Comments Due Nov 26 / Dec 16): Filing Timing, Budget Review and Fee-Reduction Checks for Pharma & Bio SMEs

Under the fee amendment MFDS proposed on November 6, approval fees for new biologics would rise from KRW 8.03 million to KRW 20.71 million, and fees for data-submission drugs would go up about sixfold. This guide shows pharma and bio SMEs how to review their filing timing, budgets, fee-reduction eligibility and public comments.

2026-11-09
Management Consulting

Factories With 20–49 Workers Will Need a Safety or Health Manager — Korea's First Tripartite Agreement on November 5 (About 30,000 Sites in 5 Industries Including Manufacturing, Decree Amendment in 2027, Target Start 2028), the Owner-Led Alternative and Government Payroll Support: A Preparation Guide for Small Manufacturers

Under Korea's November 5 tripartite agreement, about 30,000 sites with 20–49 workers in manufacturing and four other industries are expected to need a qualified safety or health manager from 2028. This guide covers what is settled and what is still open, the owner-led alternative, a cost comparison, and a preparation checklist.

2026-11-09
Smart Factory

The Government Pays for the Build, You Pay to Keep It Running — Software Subscriptions and AI Model Retraining Costs Outside the 2027 Manufacturing-AI Smart Factory Support, and How SMEs Should Budget 3–5 Years of Operation Before Applying

The 2027 Manufacturing-AI Smart Factory program reportedly offers up to KRW 200 million (70% support outside the capital region), but software subscriptions and AI retraining costs fall outside its scope. This guide shows how to build a 3–5 year TCO table, negotiate vendor terms, and present an operating plan in your proposal before you apply.

2026-11-09
Updated daily

Let AI find government support programs in this field

Complete a 3-minute company assessment and we will recommend programs that fit your company, each with a match score. It is free.

Get AI-Matched Programs for Free

Need Consulting?

Our technology innovation consultants will propose the optimal solution for your company.